Recent 8-K filings for CELZ

• December 31, 2025, 6:59 PM ET other material materiality 0.15 neutral item 5.07item 9.01

  Shareholders approve exercise of warrants for 2.79M shares of Creative Medical Technology

  Warrants to purchase 2,790,340 shares issued Oct 29, 2025, approved at Dec 26 special meeting.

• December 19, 2025, 6:59 PM ET other materiality 0.15 neutral item 5.07item 9.01

  All five director nominees elected at 2025 annual meeting; say-on-pay and auditor ratified

  Five director nominees elected: For votes 419,951–434,837; withhold votes under 57,000 each.

• November 12, 2025, 6:59 PM ET leadership materiality 0.30 neutral item 5.02item 9.01

  Creative Medical Technology Holdings approves $100k CEO and $25k CFO bonuses

  Compensation Committee approved bonuses on November 6, 2025

• October 31, 2025, 7:59 PM ET other material materiality 0.70 neutral item 1.01item 3.02item 9.01 ◈ Equity Issuances

  CELZ raises ~$4.2M via warrant exercise inducement; issues 2.79M new warrants

  Holders of 1,116,136 warrants exercised at $3.75/share, yielding $4.2M gross proceeds.

• May 6, 2025, 7:59 PM ET other material materiality 0.15 neutral item 5.07item 9.01

  Stockholders approve exercise of warrants for 1.8M shares at special meeting

  Special meeting on May 5, 2025; 35% quorum (813,562 shares) present.

• April 11, 2025, 7:59 PM ET regulatory materiality 0.35 neutral item 3.01item 9.01 ◈ Listing & Compliance Notices

  Creative Medical receives Nasdaq notice for late clawback policy adoption; matter closed as now compliant.

  On April 8, 2025, Nasdaq notified Creative Medical for failure to timely adopt and disclose Clawback Policy per Listing Rule 5608.

• March 14, 2025, 7:59 PM ET other material materiality 0.40 neutral item 5.02item 9.01

  Creative Medical Tech awards $100k in bonuses to CEO and CFO

  CEO Timothy Warbington received a $70,000 bonus approved March 10, 2025.

• March 7, 2025, 6:59 PM ET other material materiality 0.65 neutral item 1.01item 3.02item 9.01

  Creative Medical Technology raises $3.7M via warrant exercise inducement; issues new warrants at $3.75

  Gross proceeds of ~$3.7M from cash exercise of 837,104 existing warrants at $4.42/share.

• December 26, 2024, 6:59 PM ET other material materiality 0.60 neutral item 5.03item 5.07item 9.01 ◈ Governance Changes

  Shareholders vote to increase authorized shares from 5M to 25M, approve warrant exercise

  Authorized common shares increased from 5M to 25M via Certificate of Amendment filed Dec 19, 2024.

• October 23, 2024, 7:59 PM ET other material materiality 0.60 neutral item 1.01item 9.01

  CELZ raises $1.85M in registered direct offering of shares and warrants

  Gross proceeds ~$1.85M; net ~$1.6M after fees and expenses; proceeds for working capital.

• July 25, 2024, 7:59 PM ET other material materiality 0.15 negative item 5.07item 9.01

  Creative Medical Technology Holds 2024 Annual Meeting; Say-on-Pay Vote Fails

  Five director nominees elected; Timothy Warbington and others received >300K votes for vs ~147K withhold.

• May 17, 2024, 7:59 PM ET other material materiality 0.50 neutral item 1.01item 3.02item 3.03item 5.03item 5.08item 9.01

  CEO buys one Series B Preferred share with special voting rights on share increase; annual meeting July 19

  CEO Timothy Warbington purchased one Series B Preferred share for $100; it carries 100M votes on share increase proposal.

• December 20, 2023, 6:59 PM ET other material materiality 0.15 neutral item 5.07item 9.01 ◈ Shareholder Votes ×3

  Shareholders elect all five director nominees and approve say-on-pay at annual meeting

  Quorum of 55.9% (776,982 shares) present at December 20, 2023 annual meeting.

Materiality & sentiment trend

Max materiality 0.70 · Median 0.35 · Most common event other_material

0 positive 1 negative 12 neutral

source · CELZ on sec.gov